Scotiabank raises Merck & Co's target price to $180 from $155
MRK•Scotiabank raised its target price for Merck & Co to $180 from $155.
Related News
NewGenIvf prices $1.25 million public offering at $0.07 per share
NIVF•
Nvidia turns to insurers to spread the risk of AI build-out
NVDA•
Mexico's Baja braces as Hurricane Polo nears landfall
GM•
Nasdaq halts trading in OnMed pending news at 7:50 p.m.
ONMD•
Trump reportedly denies offering Iran sanctions relief for nuclear concessions
SPY•